Brain scans reveal how Weight-Loss drug curbs cravings
NCT ID NCT02944500
First seen May 09, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This study looks at how the weight-loss drug Saxenda (liraglutide) changes brain activity related to appetite and food cravings. Researchers will use brain scans to see how the drug affects areas that control eating. The study involves 28 obese adults and aims to understand the brain mechanisms behind the drug's effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beth Israel Deaconess Medical Center General Clinical Research Center
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.